L. Alpern - Jun 9, 2023 Form 4 Insider Report for Arteris, Inc. (AIP)

Role
VP and General Counsel
Signature
/s/ Paul Alpern
Stock symbol
AIP
Transactions as of
Jun 9, 2023
Transactions value $
-$284,419
Form type
4
Date filed
6/13/2023, 04:24 PM
Previous filing
Jun 5, 2023
Next filing
Jul 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AIP Common Stock Options Exercise $24K +40K +81.71% $0.60* 89K Jun 9, 2023 Direct F1, F2, F3
transaction AIP Common Stock Sale -$308K -42.1K -47.27% $7.33 46.9K Jun 9, 2023 Direct F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AIP Stock Options (Right to Buy) Options Exercise $0 -40K -66.67% $0.00 20K Jun 9, 2023 Common Stock 40K $0.60 Direct F1, F2
holding AIP Stock Options (Right to Buy) 200K Jun 9, 2023 Common Stock 200K $0.56 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 25% of the total shares shall vest on July 23 2021; thereafter, 1/48th of the total shares shall vest monthly for 3 years. beginning on August 23, 2021.
F3 Includes 46,902 restricted stock units.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.55 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The shares subject to the stock option will vest and become exercisable with respect to 25% of the shares on August 26, 2020 and in 36 substantially equal monthly installments thereafter.